C. IgG antibodies against platelet factor 4–heparin complexes activating platelets
Why this is correct
Immune heparin-induced thrombocytopenia involves IgG against complexes of platelet factor 4 and heparin. Antibody–Fcγ receptor engagement activates platelets and amplifies thrombin generation, producing thrombosis despite a falling platelet count. Typical onset is 5–10 days after exposure, though rapid onset can occur with recent heparin exposure. Suspected high-probability HIT requires prompt cessation of heparin and use of an appropriate nonheparin anticoagulant.
Why each option is correct or incorrect
Immune HIT is not simply a direct marrow-suppressive adverse effect.
Type I immediate IgE allergy is not the PF4-mediated platelet activation mechanism.
Correct: pathogenic anti-PF4/heparin IgG activates platelets and drives thrombosis.
Reduced vitamin K-dependent factor synthesis is the mechanism of warfarin, not HIT.
High-yield notes
- HIT: falling platelets plus thrombosis after heparin exposure.
- Antibody target: PF4–heparin complex.
- Anti-PF4 IgG platelet activation creates a hypercoagulable state.
Thrombocytopenia does not exclude thrombosis—HIT is a classic paradox.
A postoperative platelet fall alone is not sufficient for HIT; timing, thrombosis and alternative causes must be assessed.